Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Cancer prevalence higher in stroke patients than in the general population: the Dutch String-of-Pearls Institute (PSI) Stroke study.

Wilbers J, Sondag L, Mulder S, Siegerink B, van Dijk EJ; Dutch String-of-Pearls Stroke Study Group.

Eur J Neurol. 2019 Jul 12. doi: 10.1111/ene.14037. [Epub ahead of print]

PMID:
31299123
2.

Migraine and venous thrombosis: Another important piece of the puzzle.

Siegerink B, Adelborg K.

Res Pract Thromb Haemost. 2019 May 12;3(3):309-311. doi: 10.1002/rth2.12209. eCollection 2019 Jul. No abstract available.

3.

Intrinsic Coagulation Pathway, History of Headache, and Risk of Ischemic Stroke.

van Os HJA, Wermer MJH, Rosendaal FR, Govers-Riemslag JW, Algra A, Siegerink BS.

Stroke. 2019 Aug;50(8):2181-2186. doi: 10.1161/STROKEAHA.118.023124. Epub 2019 Jul 9.

PMID:
31284847
4.

Result dissemination from clinical trials conducted at German university medical centers was delayed and incomplete.

Wieschowski S, Riedel N, Wollmann K, Kahrass H, Müller-Ohlraun S, Schürmann C, Kelley S, Kszuk U, Siegerink B, Dirnagl U, Meerpohl J, Strech D.

J Clin Epidemiol. 2019 Jun 10;115:37-45. doi: 10.1016/j.jclinepi.2019.06.002. [Epub ahead of print]

PMID:
31195110
5.

Measuring functional limitations after venous thromboembolism: A call to action.

Klok FA, Barco S, Siegerink B.

Thromb Res. 2019 Jun;178:59-62. doi: 10.1016/j.thromres.2019.04.003. Epub 2019 Apr 7. Review.

PMID:
30980999
6.

Exact replication: Foundation of science or game of chance?

Piper SK, Grittner U, Rex A, Riedel N, Fischer F, Nadon R, Siegerink B, Dirnagl U.

PLoS Biol. 2019 Apr 9;17(4):e3000188. doi: 10.1371/journal.pbio.3000188. eCollection 2019 Apr.

7.

Hypercoagulability and the risk of recurrence in young women with myocardial infarction or ischaemic stroke: a cohort study.

Maino A, Algra A, Peyvandi F, Rosendaal FR, Siegerink B.

BMC Cardiovasc Disord. 2019 Mar 7;19(1):55. doi: 10.1186/s12872-019-1040-4.

8.

Myocardial injury in transient global amnesia: a case-control study.

Erdur H, Siegerink B, Ganeshan R, Audebert HJ, Endres M, Nolte CH, Scheitz JF.

Eur J Neurol. 2019 Jul;26(7):986-991. doi: 10.1111/ene.13920. Epub 2019 Feb 21.

PMID:
30706590
9.

Impact of your results: Beyond the relative risk.

Siegerink B, Rohmann JL.

Res Pract Thromb Haemost. 2018 Sep 30;2(4):653-657. doi: 10.1002/rth2.12148. eCollection 2018 Oct.

10.

Return to work after ischemic stroke in young adults: A registry-based follow-up study.

Aarnio K, Rodríguez-Pardo J, Siegerink B, Hardt J, Broman J, Tulkki L, Haapaniemi E, Kaste M, Tatlisumak T, Putaala J.

Neurology. 2018 Nov 13;91(20):e1909-e1917. doi: 10.1212/WNL.0000000000006510. Epub 2018 Oct 12.

11.

High-sensitivity cardiac troponin T and severity of cerebral white matter lesions in patients with acute ischemic stroke.

von Rennenberg R, Siegerink B, Ganeshan R, Villringer K, Doehner W, Audebert HJ, Endres M, Nolte CH, Scheitz JF.

J Neurol. 2019 Jan;266(1):37-45. doi: 10.1007/s00415-018-9085-3. Epub 2018 Oct 11.

PMID:
30311052
12.

Genetic determinants of activity and antigen levels of contact system factors.

Rohmann JL, de Haan HG, Algra A, Vossen CY, Rosendaal FR, Siegerink B.

J Thromb Haemost. 2019 Jan;17(1):157-168. doi: 10.1111/jth.14307. Epub 2018 Nov 2.

PMID:
30288888
13.

Outcome after stroke attributable to baseline factors-The PROSpective Cohort with Incident Stroke (PROSCIS).

Malsch C, Liman T, Wiedmann S, Siegerink B, Georgakis MK, Tiedt S, Endres M, Heuschmann PU.

PLoS One. 2018 Sep 26;13(9):e0204285. doi: 10.1371/journal.pone.0204285. eCollection 2018.

14.

FVIII, Protein C and the Risk of Arterial Thrombosis: More than the Sum of Its Parts.

Siegerink B.

Thromb Haemost. 2018 Jul;118(7):1127-1129. doi: 10.1055/s-0038-1661373. Epub 2018 Jul 2. No abstract available.

PMID:
29966165
15.

Neighborhood characteristics, bystander automated external defibrillator use, and patient outcomes in public out-of-hospital cardiac arrest.

Andersen LW, Holmberg MJ, Granfeldt A, Løfgren B, Vellano K, McNally BF, Siegerink B, Kurth T, Donnino MW; CARES Surveillance Group.

Resuscitation. 2018 May;126:72-79. doi: 10.1016/j.resuscitation.2018.02.021. Epub 2018 Mar 2.

PMID:
29477731
16.

Outcome of pregnancies and deliveries before and after ischaemic stroke.

Aarnio K, Gissler M, Grittner U, Siegerink B, Kaste M, Tatlisumak T, Tikkanen M, Putaala J.

Eur Stroke J. 2017 Dec;2(4):346-355. doi: 10.1177/2396987317723795. Epub 2017 Jul 28.

17.

Pulmonary dysfunction and development of different cardiovascular outcomes in the general population.

Padberg I, Schneider A, Grittner U, Olma MC, Liman T, Siegerink B.

Arch Cardiovasc Dis. 2018 Apr;111(4):246-256. doi: 10.1016/j.acvd.2017.07.001. Epub 2017 Nov 4.

18.

Berlin prehospital or usual delivery of acute stroke care - Study protocol.

Ebinger M, Harmel P, Nolte CH, Grittner U, Siegerink B, Audebert HJ.

Int J Stroke. 2017 Aug;12(6):653-658. doi: 10.1177/1747493017700152. Epub 2017 Mar 22.

PMID:
28649936
19.

A Prothrombotic Score Based on Genetic Polymorphisms of the Hemostatic System Differs in Patients with Ischemic Stroke, Myocardial Infarction, or Peripheral Arterial Occlusive Disease.

Herm J, Hoppe B, Siegerink B, Nolte CH, Koscielny J, Haeusler KG.

Front Cardiovasc Med. 2017 Jun 9;4:39. doi: 10.3389/fcvm.2017.00039. eCollection 2017.

20.

Contribution of Established Stroke Risk Factors to the Burden of Stroke in Young Adults.

Aigner A, Grittner U, Rolfs A, Norrving B, Siegerink B, Busch MA.

Stroke. 2017 Jul;48(7):1744-1751. doi: 10.1161/STROKEAHA.117.016599. Epub 2017 Jun 15.

PMID:
28619986
21.

Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Triggers, Causes, and Outcome (SECRETO): Rationale and design.

Putaala J, Martinez-Majander N, Saeed S, Yesilot N, Jäkälä P, Nerg O, Tsivgoulis G, Numminen H, Gordin D, von Sarnowski B, Waje-Andreassen U, Ylikotila P, Roine RO, Zedde M, Huhtakangas J, Fonseca C, Redfors P, de Leeuw FE, Pezzini A, Kõrv J, Schneider S, Tanislav C, Enzinger C, Jatuzis D, Siegerink B, Martínez-Sánchez P, Grau AJ, Palm F, Groop PH, Lanthier S, Ten Cate H, Pussinen P, Paju S, Sinisalo J, Lehto M, Lindgren A, Ferro J, Kittner S, Fazekas F, Gerdts E, Tatlisumak T.

Eur Stroke J. 2017 Jun;2(2):116-125. doi: 10.1177/2396987317703210. Epub 2017 Apr 4.

22.

Statin use and risk of recurrent venous thrombosis: results from the MEGA follow-up study.

Brækkan SK, Caram-Deelder C, Siegerink B, van Hylckama Vlieg A, le Cessie S, Rosendaal FR, Cannegieter SC, Lijfering WM.

Res Pract Thromb Haemost. 2017 May 25;1(1):112-119. doi: 10.1002/rth2.12003. eCollection 2017 Jul.

23.

Increasing efficiency of preclinical research by group sequential designs.

Neumann K, Grittner U, Piper SK, Rex A, Florez-Vargas O, Karystianis G, Schneider A, Wellwood I, Siegerink B, Ioannidis JP, Kimmelman J, Dirnagl U.

PLoS Biol. 2017 Mar 10;15(3):e2001307. doi: 10.1371/journal.pbio.2001307. eCollection 2017 Mar.

24.

Setting up your own research group.

Siegerink B.

J Thromb Haemost. 2016 Dec;14(12):2339-2341. doi: 10.1111/jth.13531. Epub 2016 Nov 17.

25.

Clinical and laboratory predictors of deep vein thrombosis after acute stroke; does D-dimer really improve predictive power?

Kola V, de Haan H, Siegerink B.

Thromb Res. 2016 Oct;146:131-132. doi: 10.1016/j.thromres.2016.07.001. Epub 2016 Jul 5. No abstract available.

PMID:
27424275
26.

Cardiovascular events after ischemic stroke in young adults: A prospective follow-up study.

Aarnio K, Siegerink B, Pirinen J, Sinisalo J, Lehto M, Haapaniemi E, Nave AH, Kaste M, Tatlisumak T, Putaala J.

Neurology. 2016 May 17;86(20):1872-9. doi: 10.1212/WNL.0000000000002689. Epub 2016 Apr 20.

PMID:
27164672
27.

Pregnancy loss and risk of ischaemic stroke and myocardial infarction.

Maino A, Siegerink B, Algra A, Martinelli I, Peyvandi F, Rosendaal FR.

Br J Haematol. 2016 Jul;174(2):302-9. doi: 10.1111/bjh.14043. Epub 2016 Apr 7.

PMID:
27061416
28.

Statins and risk of poststroke hemorrhagic complications.

Scheitz JF, MacIsaac RL, Abdul-Rahim AH, Siegerink B, Bath PM, Endres M, Lees KR, Nolte CH; VISTA collaboration.

Neurology. 2016 Apr 26;86(17):1590-6. doi: 10.1212/WNL.0000000000002606. Epub 2016 Mar 25.

29.

Where Have All the Rodents Gone? The Effects of Attrition in Experimental Research on Cancer and Stroke.

Holman C, Piper SK, Grittner U, Diamantaras AA, Kimmelman J, Siegerink B, Dirnagl U.

PLoS Biol. 2016 Jan 4;14(1):e1002331. doi: 10.1371/journal.pbio.1002331. eCollection 2016 Jan.

30.

Ankle-Brachial Index and Recurrent Stroke Risk: Meta-Analysis.

Hong JB, Leonards CO, Endres M, Siegerink B, Liman TG.

Stroke. 2016 Feb;47(2):317-22. doi: 10.1161/STROKEAHA.115.011321. Epub 2015 Dec 10. Review.

PMID:
26658450
31.

Recurrence and Mortality in Young Women With Myocardial Infarction or Ischemic Stroke: Long-term Follow-up of the Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) Study.

Maino A, Siegerink B, Algra A, Peyvandi F, Rosendaal FR.

JAMA Intern Med. 2016 Jan;176(1):134-6. doi: 10.1001/jamainternmed.2015.6523. No abstract available.

PMID:
26595612
32.

Spectrum of cerebral spinal fluid findings in patients with posterior reversible encephalopathy syndrome.

Neeb L, Hoekstra J, Endres M, Siegerink B, Siebert E, Liman TG.

J Neurol. 2016 Jan;263(1):30-4.

PMID:
26477022
33.

Lipoprotein (a) as a risk factor for ischemic stroke: a meta-analysis.

Nave AH, Lange KS, Leonards CO, Siegerink B, Doehner W, Landmesser U, Steinhagen-Thiessen E, Endres M, Ebinger M.

Atherosclerosis. 2015 Oct;242(2):496-503. doi: 10.1016/j.atherosclerosis.2015.08.021. Epub 2015 Aug 15.

PMID:
26298741
34.

Hypercoagulability Is a Stronger Risk Factor for Ischaemic Stroke than for Myocardial Infarction: A Systematic Review.

Maino A, Rosendaal FR, Algra A, Peyvandi F, Siegerink B.

PLoS One. 2015 Aug 7;10(8):e0133523. doi: 10.1371/journal.pone.0133523. eCollection 2015. Review.

35.

Hypercoagulability and the risk of myocardial infarction and ischemic stroke in young women.

Siegerink B, Maino A, Algra A, Rosendaal FR.

J Thromb Haemost. 2015 Sep;13(9):1568-75. doi: 10.1111/jth.13045. Epub 2015 Aug 21.

36.

Plasma ADAMTS-13 levels and the risk of myocardial infarction: an individual patient data meta-analysis.

Maino A, Siegerink B, Lotta LA, Crawley JT, le Cessie S, Leebeek FW, Lane DA, Lowe GD, Peyvandi F, Rosendaal FR.

J Thromb Haemost. 2015 Aug;13(8):1396-404. doi: 10.1111/jth.13032. Epub 2015 Jul 14. Review.

37.

[Conducting your own research: a revised recipe for a clinical research training project].

Siegerink B, Dekkers OM, Rosendaal FR.

Ned Tijdschr Geneeskd. 2015;159:A9117. Review. Dutch.

PMID:
26058772
38.

Graphical presentation of confounding in directed acyclic graphs.

Suttorp MM, Siegerink B, Jager KJ, Zoccali C, Dekker FW.

Nephrol Dial Transplant. 2015 Sep;30(9):1418-23. doi: 10.1093/ndt/gfu325. Epub 2014 Oct 16. Review.

PMID:
25324358
39.

[Mendelian randomisation].

de Haan HG, Siegerink B, van Hylckama Vlieg A.

Ned Tijdschr Geneeskd. 2014;158:A7547. Review. Dutch.

PMID:
25322353
41.

Re: "Mendelian randomization and estimation of treatment efficacy for chronic diseases".

Boef AG, Postmus I, Siegerink B.

Am J Epidemiol. 2014 Jan 15;179(2):264. doi: 10.1093/aje/kwt306. Epub 2013 Dec 13. No abstract available.

PMID:
24335383
42.

[Case-crossover studies. Research into risk factors with the patient as his or her own control].

Roach RE, Siegerink B, Lijfering WM.

Ned Tijdschr Geneeskd. 2013;157(28):A5896. Review. Dutch.

PMID:
23841926
43.

Role of obesity in the etiology of deep vein thrombosis and pulmonary embolism: current epidemiological insights.

Braekkan SK, Siegerink B, Lijfering WM, Hansen JB, Cannegieter SC, Rosendaal FR.

Semin Thromb Hemost. 2013 Jul;39(5):533-40. doi: 10.1055/s-0033-1343355. Epub 2013 Apr 27. Review.

PMID:
23625755
44.

Association of high body mass index with decreased treatment response to combination therapy in recent-onset rheumatoid arthritis patients.

Heimans L, van den Broek M, le Cessie S, Siegerink B, Riyazi N, Han KH, Kerstens PJ, Huizinga TW, Lems WF, Allaart CF.

Arthritis Care Res (Hoboken). 2013 Aug;65(8):1235-42. doi: 10.1002/acr.21978.

45.

[Cross-over studies].

Bonten TN, Siegerink B, van der Bom JG.

Ned Tijdschr Geneeskd. 2013;157(3):A5542. Review. Dutch.

PMID:
23328025
46.

Coffee consumption is associated with a reduced risk of venous thrombosis that is mediated through hemostatic factor levels.

Roach RE, Siegerink B, le Cessie S, Rosendaal FR, Cannegieter SC, Lijfering WM.

J Thromb Haemost. 2012 Dec;10(12):2519-25. doi: 10.1111/jth.12034.

47.

Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.

Siegerink B, Maas R, Vossen CY, Schwedhelm E, Koenig W, Böger R, Rothenbacher D, Brenner H, Breitling LP.

Clin Res Cardiol. 2013 Mar;102(3):193-202. doi: 10.1007/s00392-012-0515-4. Epub 2012 Oct 17.

PMID:
23073705
48.

High-molecular-weight kininogen and the risk of a myocardial infarction and ischemic stroke in young women: the RATIO case-control study.

Siegerink B, Rosendaal FR, Algra A.

J Thromb Haemost. 2012 Nov;10(11):2409-12. doi: 10.1111/j.1538-7836.2012.04927.x. No abstract available.

49.

Injury pattern, injury severity, and mortality in 33,495 hospital-admitted victims of motorized two-wheeled vehicle crashes in The Netherlands.

Leijdesdorff HA, Siegerink B, Sier CF, Reurings MC, Schipper IB.

J Trauma Acute Care Surg. 2012 May;72(5):1363-8. doi: 10.1097/TA.0b013e318250cced.

PMID:
22673267
50.

Family history differs between young women with myocardial infarction and ischemic stroke: results from the RATIO case-control study.

Siegerink B, Rosendaal FR, Algra A.

Atherosclerosis. 2012 Jul;223(1):235-8. doi: 10.1016/j.atherosclerosis.2012.04.024. Epub 2012 May 7.

Supplemental Content

Loading ...
Support Center